Meanwhile, the Chinese government approved a coronavirus vaccine candidate for use by the country’s military for one year, its maker said. CanSino Biologics says it has seen promising results for the vaccine in early trials. The vaccine candidate was developed by the pharmaceutical company and a research institute at China’s Academy of Military Science. Context: The CanSino product is one of eight Chinese vaccine candidates approved for human trials. The Times is providing free access to much of our coronavirus coverage, and our Coronavirus Briefing newsletter — like all of our newsletters — is free.

Source: New York Times June 30, 2020 04:34 UTC